| MolName | 3-[(2E)-2-[[1-(3-sulfopropyl)benzo[e][1,3]benzothiazol-1-ium-2-yl]methylidene]-1,3-benzothiazol-3-yl]propane-1-sulfonic acid |
| MolecularFormula | C25H25N2O6S4 |
| Smiles | OS(CCCN1c(cccc2)c2S/C1=C/c1[n+](CCCS(O)(=O)=O)c(c2ccccc2cc2)c2s1)(=O)=O |
| InChI | InChI=1S/C25H24N2O6S4/c28-36(29,30)15-5-13-26-20-9-3-4-10-21(20)34-23(26)17-24-27(14-6-16-37(31,32)33)25-19-8-2-1-7-18(19)11-12-22(25)35-24/h1-4,7-12,17H,5-6,13-16H2,(H-,28,29,30,31,32,33)/p+1 |
| InChIK | YDTLZANSZKVIOB-UHFFFAOYSA-O |
| TotalMolweight | 577.746 |
| Molweight | 577.746 |
| MonoisotopicMass | 577.059543 |
| CLogP | -2.3733 |
| CLogS | -5.482 |
| H Acceptors | 8 |
| H Donors | 2 |
| TotalSurfaceArea | 386.88 |
| Relative PSA | 0.32961 |
| PolarSurfaceArea | 186.16 |
| Druglikeness | -7.7617 |
| Mutagenic | low |
| Tumorigenic | low |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB; tert. immonium |
| Shape Index | 0.40541 |
| Fragments | 1 |
| Non HAtoms | 37 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| Rotatable Bond | 9 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 19 |
| Sp3Atoms | 12 |
| Symmetricatoms | 2 |
| Aromatic Nitrogens | 1 |
| AcidicOxygens | 2 |
| StereoCon |
Click to Load Molecule:
1 - 3-[(2E)-2-[[1-(3-sulfopropyl)benzo[e][1,3]benzothiazol-1-ium-2-yl]methylidene]-1,3-benzothiazol-3-yl]propane-1-sulfonic acid | 2 - 3-[(2E)-2-[[1-(3-sulfopropyl)benzo[e][1,3]benzothiazol-1-ium-2-yl]methylidene]-1,3-benzothiazol-3-yl]propane-1-sulfonic acid